BioSpace News Archive

The Mollie Biggane Melanoma Foundation has joined forces with ELIH to provide patients with skin cancer assessment and education.

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), named University of Virginia Children’s Hospital to be the 22nd Certified Duchenne Care Center.

NanoSphere Health Sciences, Inc. (CSE: NSHS) (OTC: NSHSF) announces revised terms for its non-brokered private placement previously announced on Nov. 16, 2018.

ARxIUM, a global provider of industry-leading pharmacy automation, workflow and consulting solutions, today announced the launch of its cGMP RIVA IV compounding system for 503B central-fill, hospital and outsourcing pharmacies

Generex Biotechnology Corporation (OTCMKTS:GNBT) announced today the appointment of Anthony J. Dolisi as Generex Chief Commercial Officer and Michelle Starr as Generex Chief Marketing Officer.

Northeast Arc announced winners of the 2nd “The Arc Tank” competition created to positively disrupt conventional methods of providing services to persons with disabilities.

Biovation Labs, a leading supplement contract manufacturer, today announced it is expanding its capabilities to better serve its clients with the installation of an Aquarius G-J high speed rotary tablet press from Kikusui.

Grand Opening Event debuting Artificial Intelligence-powered, virtual medical clinics inside Phoenix-area Safeway stores. Mayor Mark Mitchell to host ribbon cutting and make remarks.

Navidea Biopharmaceuticals, Inc. today announced that its Chief Executive Officer, Jed Latkin, will present a corporate overview of the Company at the 11th Annual LD Micro Event, being held December 4-6, 2018 in Bel-Air, California.

MabVax Therapeutics Holdings, Inc. today announced that the Company had entered into an equity purchase agreement with Triton Funds LP, a Delaware limited partnershiP, in which Triton Funds has agreed to purchase up to $1,000,000 of the Company’s to be designated Series P Convertible Preferred Stock, par value of $0.01 per share